Position in OVID
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$529,082
-$201,129 QoQ
Shares Held
196,685
-40.2% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 131 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OVID Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $1,244,853,716 across 210 Biotechnology names. OVID ranks #113 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
255,073 | $236,649,076 | |
| 2 | INSM |
INSMED Inc
|
1,015,870 | $108,312,059 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
129,981 | $64,565,461 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,166,715 | $63,480,962 | |
| 5 | ASND |
Ascendis Pharma A/S
|
237,869 | $63,444,419 | |
| 6 | INCY |
Incyte Corp
|
498,013 | $56,454,752 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
551,116 | $43,135,848 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,441 | $37,687,380 |
All Filings in OVID
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $529,082 | 196,685 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $730,211 | 328,924 | Shares | Sole | 2026-05-13 | |
| 2022-12-31 | $62,927 | 33,832 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $62,250 | 33,832 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $156,924 | 72,988 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $374,771 | 119,354 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $383,126 | 119,354 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $271,141 | 80,697 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $315,525 | 80,697 | Shares | Sole | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||